In general, higher doses of Cosentyx (secukinumab) can carry a greater risk of side effects, mainly because more of the drug is in your body and it provides stronger immunosuppression. The main safety concerns to watch for are infections (like colds, throat infections, or more serious infections), as well as potential injection-site reactions. There are also rare risks such as yeast infections (Candida), and, though uncommon, possible worsening of inflammatory bowel disease or other immune-related issues.
What varies by dose:
- The approved Cosentyx regimens use either 150 mg or 300 mg given by injection, and the dose chosen depends on the condition being treated (plaque psoriasis, psoriatic arthritis, or axial spondyloarthritis) and sometimes body weight or response.
- For plaque psoriasis, 300 mg is commonly used; for psoriatic arthritis and axial spondyloarthritis, 150 mg is common, with the option to increase to 300 mg in some cases if response is inadequate.
- Any dose change should be decided by your healthcare provider, who will weigh disease control against potential side effects and will monitor you for infections or other problems.
If you’re considering a higher dose or have already been advised to increase the dose, talk with your doctor about:
- Why the higher dose is being considered (response to treatment, disease severity, body weight, etc.)
- What specific side effects to watch for and how to monitor for infections
- Any history of infections, inflammatory bowel disease, or other immune-related conditions
If you’d like, tell me which Cosentyx condition you’re treating and what dose you’re on, and I can summarize the typical dosing and safety considerations for that scenario. And as always, consult your prescriber before making any changes.